NEW YORK (GenomeWeb) – Cowen and Company has initiated coverage of Exact Sciences at a rating of Outperform and a price target of $30.
NEW YORK (GenomeWeb) – Cowen and Company has initiated coverage of Exact Sciences at a rating of Outperform and a price target of $30.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.